Linqi Zhang mainly focuses on Virology, Immunology, Viral replication, Virus and Genotype. His biological study spans a wide range of topics, including Vaccinia, Orthopoxvirus and Recombinant virus. He interconnects Gene rearrangement and Pharmacotherapy in the investigation of issues within Immunology.
His research investigates the link between Viral replication and topics such as CXCR4 that cross with problems in Cell, In vivo and Lymph node. His work on Viral disease and Viremia as part of general Virus study is frequently linked to Coronavirus and Coronaviridae, bridging the gap between disciplines. The Genotype study which covers Coreceptor activity that intersects with Heterozygote advantage, Transmission, Multicenter AIDS Cohort Study, Allele and Host factor.
His primary areas of investigation include Virology, Immunology, Virus, Genetics and Genotype. His study on Viral load, Viral replication and Viral entry is often connected to Coronavirus as part of broader study in Virology. His research investigates the connection with Immunology and areas like Pharmacotherapy which intersect with concerns in Indinavir.
His Viral disease study in the realm of Virus connects with subjects such as Antiretroviral medication. Many of his research projects under Genetics are closely connected to Selection with Selection, tying the diverse disciplines of science together. His Genotype research incorporates themes from Transmission, Coreceptor activity, Cohort and Hepatitis C virus.
The scientist’s investigation covers issues in Virology, Coronavirus, Virus, Coronaviridae and Neutralizing antibody. Linqi Zhang combines subjects such as Genetics, Antibody and Immunology with his study of Virology. The concepts of his Immunology study are interwoven with issues in Regimen and Modified vaccinia Ankara.
As part of one scientific family, Linqi Zhang deals mainly with the area of Virus, narrowing it down to issues related to the DNA vaccination, and often Titer, Microbiology and Escherichia coli. His Neutralizing antibody study incorporates themes from Heterologous, Immunity and Vaccination. His Viral disease study combines topics from a wide range of disciplines, such as Disease and Immune system.
Linqi Zhang mostly deals with Virus, Coronaviridae, Coronavirus, Virology and Viral Vaccine. Linqi Zhang incorporates a variety of subjects into his writings, including Coronavirus, Neutralizing antibody, Tissue tropism, Recombinant virus and Antibody. His work carried out in the field of Tissue tropism brings together such families of science as Viral entry, DNA vaccination and Immunogenicity.
His Recombinant virus research integrates issues from Vaccinia and Orthopoxvirus. His Antibody study is focused on Immunology in general.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Yaoxing Huang;William A. Paxton;Steven M. Wolinsky;Avidan U. Neumann.
Nature Medicine (1996)
Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.
Linqi Zhang;B. Ramratnam;K. Tenner-Racz;Yuxian He.
The New England Journal of Medicine (1999)
Contribution of Human α-Defensin-1, -2 and -3 to the Anti-HIV-1 Activity of CD8 Antiviral Factor
Linqi Zhang;Wenjie Yu;Tian He;Jian Yu.
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.
Bharat Ramratnam;John E. Mittler;Linqi Zhang;Daniel Boden.
Nature Medicine (2000)
Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis
Bharat Ramratnam;Sebastian Bonhoeffer;James Binley;Arlene Hurley.
The Lancet (1999)
A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
Leondios G. Kostrikis;Yaoxing Huang;John P. Moore;Steve M. Wolinsky.
Nature Medicine (1998)
Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy.
Linqi Zhang;Sharon R. Lewin;Martin Markowitz;Hsi-Hsun Lin.
Journal of Experimental Medicine (1999)
Genetic characterization of New West African simian immunodeficiency virus SIVsm: geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop.
Z Chen;P Telfier;A Gettie;P Reed.
Journal of Virology (1996)
Human immunodeficiency virus type 2 (HIV-2) seroprevalence and characterization of a distinct HIV-2 genetic subtype from the natural range of simian immunodeficiency virus-infected sooty mangabeys.
Zhiwei Chen;Amara Luckay;Donald L. Sodora;Paul Telfer.
Journal of Virology (1997)
HIV-1 subtype and second-receptor use
Linqi Zhang;Yaoxing Huang;Tian He;Yunzhen Cao.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: